Hodgkin's lymphoma (relapsed or refractory): autologous stem cell therapy.
Amin RahemtullaEvangelos TerposPublished in: BMJ clinical evidence (2015)
In this systematic overview, we categorised the efficacy for one intervention, based on information relating to the effectiveness and safety of high-dose chemotherapy plus autologous stem cell therapy (versus conventional chemotherapy).
Keyphrases
- cell therapy
- high dose
- diffuse large b cell lymphoma
- hodgkin lymphoma
- stem cells
- locally advanced
- mesenchymal stem cells
- randomized controlled trial
- acute lymphoblastic leukemia
- acute myeloid leukemia
- low dose
- stem cell transplantation
- multiple myeloma
- rectal cancer
- squamous cell carcinoma
- healthcare
- health information
- bone marrow